Skip to main content

Table 1 The anthropometric, clinical, and metabolic characterizations of all participants

From: Principal component analysis of adipose tissue gene expression of lipogenic and adipogenic factors in obesity

 

Women with normal-weight (n = 22)

Women with obesity (n = 24)

Total difference p-value

Age, years

37.68 ± 9.07

34.91 ± 6.61

0.241

BMI, Kg/m2

23.30 (22.84–24.34)

42.59(36.38–46.10)

0.000

VAI,-

1.75 (1.27–2.20)

2.27 (1.34–3.03)

0.132

LAP,-

25.87 ± 13.12

76.69 ± 36.86

0.000

WC(cm)

85 (83–87)

114(111.5–119)

0.000

HC (cm)

95(90–97)

128 (120–133)

0.000

WHR

0.88 ± 0.05

0.91 ± 0.057

0.088

BAI, -

27.81 ± 3.22

43.89 ± 6.79

0.000

WWI,-

10.66 ± 0.7

11.08 ± 0.84

0.073

CI,-

0.89 ± 0.09

1.09 ± 0.11

0.000

AVI,-

14.54 (13.88–15.18)

26.22(25.16–28.59)

0.000

WHtR,-

0.51 ± 0.04

0.72 ± 0.058

0.000

SBP, mmHg

116.09 ± 11.44

121.04 ± 14.52

0.228

DBP, mmHg

75.23 ± 7.63

77.62 ± 12.53

0.568

FBG, mg/dL

85.21 ± 7.28

88.99 ± 8.71

0.119

Fasting Insulin, µU/mL

8.02 ± 3.57

19.42 ± 4.69

0.000

HOMA-IR, -

1.68 ± 0.75

4.25 ± 1.07

0.000

Urea, mg/dL

22.60 ± 7.54

26.53 ± 6.07

0.057

Creatinine, mg/dL

0.58 ± 0.15

0.73 ± 0.11

0.001

Uric acid, mg/dL

4.00 ± 0.83

5.51 ± 1.06

0.000

AST, U/L

16.7(11.7–20.95)

20.65 (16.2–23.95)

0.170

ALT, U/L

12.55 (11.07–20.25)

20.30 (15.35–30.20)

0.209

HDL-C, mg/dL

44.02 ± 7.33

44.95 ± 7.29

0.667

LDL-C,mg/dL

88.69 ± 28.93

113.41 ± 19.65

0.001

TC, mg/dL

147.41 ± 37.60

180.41 ± 25.48

0.001

TG, mg/dL

91.55 (69.70–127.70)

105.95 (67.6–145.3)

0.960

hs-CRP, mg/L

1.8(1.01–2.5)

5.69 (3–11.02)

0.000

  1. Continuous variables with normal and non-normal distribution were described as the mean ± SD and median (IQR), respectively
  2. BMI, body mass index; VAI, visceral adiposity index; BAI, body adiposity index; VI, abdominal volume index; WWI, weight-adjusted waist index; CI; conicity index; WC, waist circumference; HC, hip circumference; WHR, waist-to-hip ratio; WHtR, Waist to Height Ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TG, triglycerides; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; AST, aspartate aminotransferase; ALT, alanine aminotransferase; hs-CRP, high-sensitivity C-reactive Protein; AMH, anti-mullerian hormone; HOMA-IR, homeostasis model assessment of insulin resistance; HbA1c, hemoglobin A1C
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us